Exosome as the Prognostic and Predictive Biomarker in EBC Patients
Status: ACTIVE_NOT_RECRUITING
Study type: INTERVENTIONAL
Conditions: Triple Negative Breast Cancer|HER2-positive Breast Cancer
Interventions: PROCEDURE: exosome and ctDNA evaluation
Sponsor: Samsung Medical Center